ERYTECH Pharma signs licensing and distribution agreement with Orphan Europe for GRASPA® in Europe

  • Auteur/autrice de la publication :
  • Post category:Newsroom

Erytech Pharma announced today that it has entered into a definitive agreement and Orphan Europe, part of the Recordati Group, granting Orphan Europe exclusive rights for the commercialization and distribution of GRASPA® in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML) in Europe.